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Mediastinal Lymphadenectomy improves survival. Evidence from 
a systematic review of surgery for NSCLC
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Objectives: To compare the effectiveness of different surgical ap-
proaches in improving disease-speciﬁc mortality in patients with stages 
I to IIIA non-small cell lung cancer (NSCLC).
Methods: A systematic review of randomised controlled trials of 
surgery for non-small cell lung cancer was undertaken. Studies were 
identiﬁed from electronic databases, bibliographies, hand searching of 
a journal and discussion with experts.
Results: In pooled analysis of 848 patients in three trials (ﬁgure 1), 
4-year survival was superior in patients undergoing resection with stage 
I to IIIA NSCLC who had complete mediastinal lymph node dissection 
compared with lymph node sampling; the hazard ratio estimated at 0.78 
(95% CI: 0.65-0.93). 30-day mortality was no different between the 
arms (p=0.84).
A single study compared 5-year survival in 100 patients randomised to 
VATS versus conventional lobectomy in patients with clinical stage IA 
NSCLC and showed no difference in 5-year survival (90% vs. 85%, 
p=0.46).
A further trial found an increased rate of local recurrence in patients 
with stage I NSCLC treated with limited resection compared with 
lobectomy (RR 2.84, p=0.007).
Conclusions: Current evidence suggests that complete mediastinal 
lymph node dissection is associated with improved survival compared 
with node sampling in patients with stage I to IIIA NSCLC undergoing 
resection. Limited resection (less than lobectomy) is associated with a 
higher rate of loco-regional recurrence and a non-signiﬁcant trend to 
poorer survival. This has implications for the accepted standard of care 
for resectable NSCLC.
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treatment of stage III central lung cancer
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Objective: To investigate the feasibility of previously blocking both 
pulmonary artery and veins for surgical treatment of central lung cancer 
with stage III to preserve the normal function of pulmonary tissue.
Methods: Firstly, the relation of the pulmonary artery, the lung 
neoplasm and the enlarged mediastinal lymph nodes was investigated. 
If the hilum of lung remained freezing stably, the pericardium was 
opened and the pulmonary artery, the upper and lower lobe pulmonary 
veins were divided. Then those three vessels were blocked to prevent 
the blood from ﬂowing from the pulmonary artery or reﬂuence of the 
left atrium. When the pulmonary circulation was stopped, bloodless 
lobectomy and pulmonary artery angioplasty and/or anastomosis were 
performed. Then the blockers were removed, and pulmonary circula-
tion was recovered. The time of blocking pulmonary artery and veins 
were 46±2.5 minutes (20-72 minutes) and 35±1.5 minutes (16-66 
minutes) respectively.
Results: All 20 patients suffer from central lung cancer with stage III, 
whose the hila of lung remained freezing stably, received complete 
resection of the tumor. The normal function of pulmonary tissue in the 
20 patients was preserved, and the pneumonectomy did not need to per-
form. The average amount of bleeding was 256ml(180-420ml) during 
operation. All 20 patients have recovered well. 
Conclusions: Previously blocking both pulmonary artery and veins for 
surgical treatment of central lung cancer with stage III is an innovation 
in surgical technique, which makes the operation safely and easily. This 
technique provides a chance to some patients, whose cardio-pulmonary 
function is too poor to tolerate pneumonectomy, to receive surgical 
treatments. Also, this technique widens the surgical indications for 
patients suffer from lung cancer.
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Background: Bronchoplasty for lung cancer has been widely accepted 
and became a reliable and safe procedure to preserve lung function. 
However, pulmonary angioplastic procedure is seldome to be done 
and there have been only a few reports about pulmonary vascular 
reconstruction. In order to identify the safety and the usefulness of the 
pulmonary angioplastic procedure with or without bronchoplasty, we 
retrospectively reviewed patients medical records in our institution.
Patients and Methods: Between January 1998 and February 2007, 
16 cases of pulmonary artery reconstruction were performed. The data 
were collected from the patient records retrospectively and analyzed. 
There were three female and 13 male patients, with a mean age of 68 
years old (range, 44- 85 years). Four cases received concurrent chemo-
radiotherapy prior to surgery and one case received induction chemo-
therapy. Bronchial anastomoses were covered with intercostal muscle 
ﬂap or pericardial fat tissue in these patients with induction therapy. 
Results: Nine cases were adenocarcinoma, and 7 cases were squamous 
cell carcinoma. Lung cancer located on left upper lobe in 9 cases, right 
upper lobe in 3 cases, right middle lobe in 2 cases, and right lower lobe 
in 2 cases, respectively. Three patients underwent bronchoplasty with 
pulmonary artery reconstruction. Mean operative time was 277±58 
minutes and mean blood loss during operation was 497±450g. Post op-
erative complications were seen in 7 cases (44%), including atelectasis 
in 3 cases, arrhythmia in 3 cases, pneumonia in 2 cases, pneumothorax 
in 1 case, and post operative bleeding combined with cerebral infarc-
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tion and acute respiratory distress syndrome in 1 case. All patients 
except one post-operative infarction case were discharged on foot, 
and their mean hospital stay after operation was 12 days. No operative 
death was seen and the overall 90-day postoperative mortality rate was 
zero. Although the mean follow up period was 23 months, the overall 
survival rate was 67%, so far.
Conclusions: Postoperative complication rate after pulmonary artery 
reconstruction was relatively high, but most of the complications were 
controllable. Lobectomy assosicated with pulmonary artery reconstruc-
tion procedure for lung cancer treatment is useful and feasible, with 
good intermediate term results. 
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Background: According to the study of regional lymphtic drainage, we 
considered reasonable lymphadenectomy contributes the post-operative 
survival of the patient with Non Small Cell Lung Cancer (NSCLC). 
And we had devised Systemic Bilateral Mediastinal Dissection and 
lung resection through a median sternotomy (ND3 operation) for 
patient with NSCLC. 
Material and Method: The patients with NSCLC who are estimated to 
be able to conventional radical operation and aged 75 year-old or less 
becomes the adaptation of ND3 operation. From Jan.1988 through Dec. 
2005, 264 patients of the left lung primary underwent ND3 operation 
and we reviewed 61 cases with c-N2 left primary NSCLC(excluding 
the patients with M1 disease).
Results: Overall 5-year survival rate in the 264 patients of left lung 
primary was 56.3%. Operative mortality in 264 patients was 4.0%, and 
in 112 patients who underwent ND3 operation from Jan.2000 through 
Dec.2005 was 1.8% .
In these c-N2(n=61) patients, over all ﬁve-year survival was 48.9%, 
and according to post-operative pathological stages were 100% in 
4 pts of p-stage IA, 68.6% in7 pts p-stagIB, 51.4% in 8 pts p-stage 
IIB,46.0% in 23 pts p-stageIIIA and 38.5% in 21 pts p-stageIIIB.
Conclusion: Our result suggested that the post-operative survival of 
patients with c-N2 NSCLC of the left lung primary would be remark-
ably improved by Systemic Bilateral Mediastinal Dissection. 
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Background: Japanese researchers have reported good correlation 
between radiologic and pathologic ﬁndings in early lung adenocarci-
nomas. For negative margin conﬁrmation, we found a technique using 
lavage and cytological examination.
Objectives: Conﬁrm limited resection efﬁcacy as radical surgery in 
patients with high resolution CT indicated minimally invasive lung 
cancer. Conﬁrm intraoperative cytology as a negative margin indicator 
and reliable margin non-recurrence predictor. 
Methods: Enrollment requires patients with a tumor ≤2 cm in diameter, 
diagnosed or suspected as a clinical T1N0M0 carcinoma in the lung 
periphery based on a CT scan. They had to have a high-resolution CT 
scan indicating a sub-solid nodule with tumor disappearance ratio; 
TDR ≥0.5. (TDR = 1- DM/DL; DM: maximum tumor diameter on 
mediastinal settings, DL: maximum tumor diameter on lung settings). 
Patients with a malignancy history within the past 5 years or those unﬁt 
for lobectomy and systematic lymph node dissection are excluded.
We perform a wedge or segmental resection. The used stapling car-
tridges are washed with 50 ml saline. Washing saline is centrifuged and 
sediment stained using Papanicolaou’s method and examined for cancer 
cells. If cytology is cancer positive, additional margin is resected, 
and cytologic examination repeated. If the second exam is positive, 
a routine lobectomy and systematic lymph node dissection will be 
performed.
Patients are followed up every 6 months by chest CT for the ﬁrst 3 
years, and annually thereafter for at least 5 years. The endpoint is 5 
year local recurrence free survival rate.
The Kanagawa Cancer Center joined the study in November 2006.
Results: This prospective study started in November 2003, and 35 
patients have been enrolled as of February 2007. This is 5.1% of all re-
sected lung cancer patients during this period. There were 12 men and 
23 women, aged 30-78, with an average 61 years. Tumor sizes ranged 
from 6 to 20 mm in the resected specimens, averaging 12 mm. There 
were 6 Noguchi type A tumors, 16 type B tumors, 9 type C tumors, 
one unclassiﬁable adenocarcinoma, and 3 inﬂammatory ﬁbroses. All 
